Middle East & Africa EPA and DHA Market Outlook, 2031

Market Drivers

• Increasing Demand for Dietary Supplements and Premium Nutrition Products: The growing availability of international dietary supplement brands through pharmacies, supermarkets, specialist nutrition stores, and e-commerce platforms is supporting the consumption of EPA and DHA products. Consumers in Gulf countries are increasingly exposed to premium nutritional formulations, including concentrated omega-3 supplements and combination products targeting specific health requirements. Manufacturers are also introducing different delivery formats, such as easy-to-consume liquids, softgels, and specialised capsules, to attract different consumer groups. The expansion of organised retail and healthcare distribution channels is improving product accessibility and supporting the development of the regional EPA and DHA market.
• Growing Application in Infant and Maternal Nutrition: The use of DHA in infant formula, maternal supplements, and specialised nutritional products is creating opportunities for ingredient suppliers across the Middle East. DHA is recognised for its role in brain and visual development, making it an important ingredient for manufacturers targeting pregnancy, early-life nutrition, and child development. Demand is supported by the availability of imported infant formula brands, growing interest in specialised maternal nutrition, and the expansion of premium nutritional product categories. Manufacturers are also exploring algae-derived DHA ingredients to provide alternative sourcing options for infant and maternal nutrition formulations.

Market Challenges

• Dependence on Imported EPA and DHA Ingredients: The Middle East relies substantially on international suppliers for refined fish oil, concentrated EPA and DHA, and algae-derived omega-3 ingredients. Limited regional capacity for specialised extraction, purification, and concentration creates dependence on overseas ingredient manufacturers. This exposes local supplement brands, food processors, and pharmaceutical companies to international raw material price fluctuations, shipping costs, currency movements, and supply-chain disruptions. Companies operating in the region must also maintain reliable supplier relationships and ensure that imported ingredients meet the required quality, purity, and documentation standards before incorporating them into finished products.
• High Product Costs and Consumer Price Sensitivity: Premium EPA and DHA products can face affordability challenges, particularly when they contain concentrated omega-3 oils, advanced delivery systems, or specialised algae-derived ingredients. Additional costs associated with purification, encapsulation, quality testing, packaging, and international transportation can increase the final product price. This creates challenges for manufacturers targeting price-sensitive consumers and markets where dietary supplement adoption is still developing. Companies need to balance ingredient concentration, product quality, and pricing to reach a broader consumer base without compromising formulation standards.

Market Trends

• Development of Concentrated and Specialised Omega-3 Formulations: Manufacturers are increasingly focusing on concentrated EPA and DHA formulations designed to deliver higher omega-3 content in convenient product formats. These formulations are being developed for consumers seeking targeted nutritional support, including cardiovascular wellness, cognitive health, and healthy ageing. Product innovation includes concentrated softgels, liquid oils, emulsions, and combination supplements. The trend is also encouraging ingredient suppliers to provide customised concentrations, formulation support, and quality documentation to meet the requirements of regional supplement and specialised nutrition manufacturers.
• Expansion of EPA and DHA Applications in Pet Nutrition: The growing availability of premium pet food and specialised animal nutrition products is creating additional opportunities for EPA and DHA ingredients in the Middle East. Omega-3 fatty acids are incorporated into pet food formulations to support skin and coat condition, joint health, and general animal wellbeing. As organised pet food retail and premium product categories develop in Gulf countries, manufacturers are exploring functional formulations that differentiate their products from conventional pet food offerings. This trend is creating opportunities for ingredient suppliers serving both human nutrition and animal nutrition manufacturers.